Pioglitazone and bladder cancer: a propensity score matched cohort study.

British Journal of Clinical Pharmacology
Li WeiIsla S Mackenzie

Abstract

To examine whether exposure to pioglitazone use is associated with increased incidence of bladder cancer in patients with type 2 diabetes mellitus. A cohort study was done in the General Practice Research Database (GPRD) between 2001 and 2010. Two hundred and seven thousand seven hundred and fourteen patients aged ≥40 years with type 2 diabetes were studied (23,548 exposed to pioglitazone and 184,166 exposed to other antidiabetic medications but not pioglitazone). The association between pioglitazone and risk of bladder cancer was assessed by a Cox regression model. A propensity score matched analysis was done in a group of patients without missing baseline characteristics data. Sixty-six and 803 new cases of bladder cancer occurred in the pioglitazone and other group, respectively (rates of 80.2 (95% CI 60.8, 99.5) and 81.8 (95% CI 76.2, 87.5) per 100,000 person-years respectively). Pioglitazone did not increase the risk of bladder cancer significantly compared with the other antidiabetic drugs treatment group, (adjusted hazard ratio (HR), 1.16, 95% CI 0.83, 1.62). In a matched propensity score analysis in which both groups had similar baseline characteristics (17,249 patients in each group), the adjusted HR was 1.22 (95% CI 0...Continue Reading

References

May 16, 1998·American Journal of Public Health·B RockhillC Weinberg
Nov 7, 1998·BMJ : British Medical Journal·D G Altman
Mar 10, 2009·The American Journal of Cardiology·Philippe MeyerAli Ahmed
Feb 24, 2010·Expert Opinion on Drug Safety·Priya Shah, Sunder Mudaliar
Jul 14, 2011·JAMA : the Journal of the American Medical Association·Joan Stephenson

❮ Previous
Next ❯

Citations

Jan 25, 2013·The Oncologist·Cristina BosettiGiovanni Corrao
Jul 28, 2012·International Journal of Molecular Sciences·Kiyoshi KikuchiEiichiro Tanaka
Jul 23, 2013·Indian Journal of Endocrinology and Metabolism·Sanjay KalraRakesh Sahay
Aug 21, 2013·Indian Journal of Endocrinology and Metabolism·Vijayam Balaji
Oct 5, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Shiyao HeYe Zhang
Nov 20, 2013·Journal of Pharmacology & Pharmacotherapeutics·Arif Hashmi
Jul 16, 2014·Pathology, Research and Practice·Bianka BojkováKarol Kajo
Sep 26, 2014·International Journal of Endocrinology·Hao-Wen Lin, Chin-Hsiao Tseng
Jul 23, 2013·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Jean-Luc FaillieDominique Hillaire-Buys
Sep 18, 2014·Expert Opinion on Investigational Drugs·Anna R Carta, Tanya Simuni
Aug 8, 2015·Pharmacoepidemiology and Drug Safety·Jason C HsuChristine Y Lu
Aug 11, 2015·British Journal of Clinical Pharmacology·Maria E GoossensFrank De Vries
May 21, 2014·Journal of Diabetes Investigation·Hiroshi NotoMitsuhiko Noda
Apr 27, 2013·British Journal of Clinical Pharmacology·Frank de VriesMaria E Goossens
Dec 5, 2014·Diabetic Medicine : a Journal of the British Diabetic Association·R E J Ryder
Dec 12, 2013·British Journal of Clinical Pharmacology·Richard M TurnerYoon K Loke
Jul 19, 2013·Diabetes, Obesity & Metabolism·E ErdmannA Perez
Sep 2, 2015·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Agata PtaszynskaKristina Johnsson
Dec 17, 2014·The Journal of Allergy and Clinical Immunology·Ruby F Fernandez-BoyanapalliDonna L Bratton
Dec 8, 2014·Diabetologia·Daniel LevinUNKNOWN Diabetes and Cancer Research Consortium
Mar 7, 2014·Journal of Environmental Science and Health. Part C, Environmental Carcinogenesis & Ecotoxicology Reviews·Chin-Hsiao Tseng
Aug 2, 2013·Diabetes Care·Guntram SchernthanerGerit-Holger Schernthaner
May 12, 2016·Archives of Toxicology·Christos V RizosMoses S Elisaf
Jan 10, 2017·Journal of the American Pharmacists Association : JAPhA·Susan Cornell
Aug 27, 2014·Molecular Pharmaceutics·Carlos N SanrameOrn Almarsson
Feb 25, 2018·Cancer Medicine·Huilin TangJiali Han
Nov 1, 2018·Diabetic Medicine : a Journal of the British Diabetic Association·E RipamontiS Suissa
Jun 18, 2017·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Elena FilipovaToni Vekov
Jul 6, 2014·Physiological Reviews·Jaap G Neels, Paul A Grimaldi
Jul 1, 2015·Expert Review of Endocrinology & Metabolism·Awadhesh Kumar Singh
Jun 19, 2015·Physiological Reviews·Emily Jane Gallagher, Derek LeRoith
Jul 28, 2017·Expert Opinion on Drug Safety·Marco TuccoriCorrado Blandizzi
Aug 18, 2017·Critical Reviews in Toxicology·Melissa A DavidsonDaniel Krewski
Oct 24, 2013·The Oncologist·Cristina BosettiGiovanni Corrao
Oct 24, 2013·The Oncologist·Frank de VriesMaria E Goossens

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.